Beyond CHOP: optimising frontline therapy in peripheral T-cell lymphoma

被引：0
|
作者：
Amin, Faisal [1 ]
Gleeson, Mary [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Clin Haematol, London, England
来源：
ANNALS OF PALLIATIVE MEDICINE | 2022年 / 11卷 / 07期
关键词：
OPEN-LABEL; PHASE-III; CYCLOPHOSPHAMIDE; VINCRISTINE; MULTICENTER; PREDNISONE; ROMIDEPSIN; PTCL;
D O I：
10.21037/apm-22-598
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：2548 / 2552
页数：5
相关论文
共 50 条
  • [1] Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP
    Wilcox, Ryan A.
    LANCET HAEMATOLOGY, 2018, 5 (05): : E182 - E183
  • [2] Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma
    Kluin-Nelemans, H. C.
    Kooy, M. van Marwijk
    Lugtenburg, P. J.
    van Putten, W. L. J.
    Luten, M.
    Oudejans, J.
    van Imhoff, G. W.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1595 - 1600
  • [3] Evolving therapy of peripheral T-cell lymphoma: 2010 and beyond
    Foss, Francine
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (03) : 161 - 173
  • [4] Advances in Frontline Management of Peripheral T-cell Lymphoma
    Abeyakoon, Chathuri
    van der Weyden, Carrie
    Harrop, Sean
    Khot, Amit
    Dickinson, Michael
    Yannakou, Costas K.
    Prince, H. Miles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 368 - 378
  • [5] Frontline autologous stem cell transplantation for peripheral T-cell lymphoma
    Gutierrez, Antonio
    Rodriguez, Jose
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (03) : 255 - 260
  • [6] A Matched-Pair Analysis of EPOCH Versus CHOP As Frontline Therapy for Nodal Peripheral T-Cell Lymphoma, Excluding ALK-Positive Anaplastic T-Cell Lymphoma: A Multicenter Experience in Thailand
    Norasetthada, Lalita
    Nawarawong, Weerasak
    Bunworasate, Udomsak
    Wudhikarn, Kitsada
    Lekhakula, Arnuparp
    Julamanee, Jakrawadee
    Numbenjapon, Tontanai
    Prayongratana, Kannadit
    Sirijerachai, Chittima
    Chansung, Kanchana
    Makruasi, Nisa
    Wongkhantee, Somchai
    Praditsuktavorn, Pannee
    Intragumtornchai, Tanin
    BLOOD, 2016, 128 (22)
  • [7] Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy
    Xue, Li-Jun
    Mao, Xiao-Bei
    Liu, Xiao-Bei
    Su, Quan-Sheng
    Yu, Hong-Ju
    Yang, Ji-Hong
    CASE REPORTS IN MEDICINE, 2010, 2010
  • [8] Prognostic Factors and the Impact of Frontline Therapy in Peripheral T-Cell Lymphoma: A Multicenter Australian Study
    Kuzich, James Anton
    Hutchison, Andrew Peter
    Lim, Kenneth
    Wright, Matthew P. F.
    Cull, Gavin
    Leahy, Michael F.
    Joske, David John Longstaff
    Radeski, Dejan
    Purtill, Duncan
    BLOOD, 2017, 130
  • [9] EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma
    Kluin-Nelemans, Hanneke C.
    Coenen, Jules L.
    Boers, James E.
    van Imhoff, Gustaaf W.
    Rosati, Stefano
    BLOOD, 2008, 112 (04) : 1039 - 1041
  • [10] How to select the frontline treatment for a patient with peripheral T-cell lymphoma
    Ansell, Stephen
    LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 783 - 788
12345